Blog
Featured post
Leading US health systems launch the Truveta Genome Project
The Truveta Genome Project creates the world’s largest and most diverse database to discover the science of humanity.
Truveta Tru, a research assistant powered by generative AI, now in Truveta Studio
We are excited to share our latest AI innovation – Truveta Tru, Truveta Studio’s research assistant powered by generative AI. Trained on the Truveta Language Model (TLM) and...
Healthcare AI: Earning trust and adoption by the research community
In the journey toward advancing healthcare research, trust in AI tools is essential. Truveta is committed to not only delivering powerful AI-driven data insights but also...
Real-time monitoring of respiratory virus-associated hospitalizations: Trends through early October 2024
Overall, the rate of hospitalizations associated with respiratory viruses decreased throughout September 2024 and into the first week of October. For infants and children aged...
Hurricane Helene: Impact of IV fluid shortage on patients
For patients coming into the emergency department (ED) with nausea/vomiting or dehydration, patients are half as likely to receive IV fluids starting 10 days after the hurricane...
GLP-1 RA prescription trends: January 2018 – September 2024
Overall prescribing rates for GLP-1 medications increased in September 2024 relative to June 2024 (+11.9%). While the rate of GLP-1 prescriptions labeled for type 2 diabetes were...
Advancing orthopedics: How device-level data is shaping the future of knee, hip, and shoulder replacements
The US market size for joint replacement is projected to balloon to nearly $38 billion by 2030, nearly doubling its 2022 value. The combination of an aging population, increasing...
Truveta recognized on national and Seattle LinkedIn Top Startup 2024 lists
Today, Truveta was featured as #3 on LinkedIn’s inaugural Top Startups in Seattle list. The ranking highlights ten growing start-up companies in the Seattle area. Last month,...
Case study: De-risking clinical development and driving therapeutic innovation in heart failure
Despite advances in guideline-directed medical therapy, heart failure (HF) readmission rates have worsened over the past decade. Optimizing acute inpatient decongestion is...
Real-time monitoring of respiratory virus-associated hospitalizations: Trends from October 2019 through August 2024
Overall, the rate of hospitalizations associated with respiratory viruses remained stable throughout August 2024, with no change compared to July 2024. For infants and children...